The Longevity Buffet — Issue 03

Welcome to the Longevity Buffet Newsletter 🗞️

REMINDER: THE AI FOR LONGEVITY HACKATHON STARTS TODAY, IN EXACTLY ONE HOUR! 🤖🧬

Opening Day is for anyone interested in the longevity space, not just hackers.

More at hackathon.londonlongevity.net

-

Jumping in to Issue 03!

RESEARCH SPOTLIGHT 🧬

Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging - Read Here

A transcriptome-based human universal senescence index (hUSI) robustly predicts cellular senescence under various conditions

Vitamin D may help preserve telomere length and hence linked to slowing cellular aging in older adults in new VITAL sub-study

FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

MARKET MOMENTUM 💸

Latest report shows funding for longevity startups went upto $8.5b in 2024, with most investment flowing to platform technologies and later-stage clinical development - Full Report

China has spent about two decades building it’s biotech sector, and is now closing the gap rapidly on the US biotech ecosystem — Read More + More

One of the largest longevity biotech companies out there, Altos Labs, recently acquired the senotherapeutics startup Dorian Therapeutics

COOL NEW TOOL 🔨

A promising new treatment for a major cause of blindness, discovered by an AI Scientist

ALPHA (the edge of having unique insights *earlier* than others/the market to drive asymmetric returns) 👀

A few ignored and under-funded areas in biotech that have the potential to be major in a few years

Additional Alpha - Enabling Vibe Bioengineering

LONDON ECOSYSTEM HIGHLIGHTS 🌃

Nucleate UK’s PlantHack, on 28 - 29 June, is a 2 day hackathon to design solutions than can advance the future of agriculture in the UK

Imperial Neurotech Society 2025 Conference coming up on 7 June

Founders Longevity Forum is back in London on 10 June, packed with exciting things, including a Bryan Johnson drop-by

That's a wrap for Issue 03!

See you again in a couple weeks,

Prasasya from London Longevity

Share your thoughts by replying to this email or joining our community on WhatsApp and LinkedIn.

Visit londonlongevity.net for upcoming announcements.